TD Asset Management’s Immunome IMNM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.63M | Sell |
605,530
-1,232
| -0.2% | -$11.5K | ﹤0.01% | 753 |
|
|
2025
Q1 | $4.08M | Buy |
606,762
+183,460
| +43% | +$1.23M | ﹤0.01% | 813 |
|
|
2024
Q4 | $4.5M | Buy |
423,302
+28,684
| +7% | +$305K | ﹤0.01% | 814 |
|
|
2024
Q3 | $5.67M | Buy |
394,618
+69,412
| +21% | +$998K | 0.01% | 770 |
|
|
2024
Q2 | $3.93M | Buy |
325,206
+39,400
| +14% | +$477K | ﹤0.01% | 818 |
|
|
2024
Q1 | $7.05M | Buy |
285,806
+158,526
| +125% | +$3.91M | 0.01% | 691 |
|
|
2023
Q4 | $1.36M | Hold |
127,280
| – | – | ﹤0.01% | 1112 |
|
|
2023
Q3 | $1.06M | Buy |
+127,280
| New | +$1.06M | ﹤0.01% | 1127 |
|